Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 300 - SKILLED NURSING AND INTERMEDIATE CARE FACILITIES CODE › Subpart C - POLICIES › Section 300.686 - Unnecessary, Psychotropic, and Antipsychotic Medications

Current through Register Vol. 48, No. 28, July 12, 2024
a) For the purposes of this Section, the
				following definitions shall apply:
1) "Adverse
				consequence" - unwanted, uncomfortable, or dangerous effects that a medication
				may have, such as impairment or decline in an individual's mental or physical
				condition or functional or psychosocial status. It may include, but is not
				limited to, various types of adverse medication reactions and interactions
				(e.g., medication-medication, medication-food, and
				medication-disease).
2)
				"Antipsychotic medication" - a medication that is used to treat symptoms of
				psychosis such as delusions, hearing voices, hallucinations, paranoia, or
				confused thoughts. Antipsychotic medications are used in the treatment of
				schizophrenia, severe depression, and severe anxiety. Older antipsychotic
				medications tend to be called typical antipsychotics. Those developed more
				recently are called atypical antipsychotics.
3) "Dose" - the total
				amount/strength/concentration of a medication given at one time or over a
				period of time. The individual dose is the amount/strength/concentration
				received at each administration. The amount received over a 24-hour period may
				be referred to as the daily dose.
4) "Duplicative therapy" - multiple
				medications of the same pharmacological class or category or any medication
				therapy that substantially duplicates a particular effect of another medication
				that the individual is taking.
5)
"Emergency"
-
has the same meaning as in Section 1-112
				of the Act
and Section
				300.330 of this Part. (Section
				2-106.1(b-3) of the Act)
6)
				"Excessive dose" - the total amount of any medication (including duplicative
				therapy) given at one time or over a period of time that is greater than the
				amount recommended by the manufacturer's label, package or insert, and the
				accepted standards of practice for a resident's age and condition.
7) "Gradual dose reduction" - the stepwise
				tapering of a dose to determine if symptoms, conditions or risks can be managed
				by a lower dose or if the dose or medication can be discontinued.
8) "Informed consent" - documented, written
				permission for specific medications, given freely, without coercion or deceit,
				by a capable resident, or by a resident's surrogate decision maker, after the
				resident, or the resident's surrogate decision maker, has been fully informed
				of, and had an opportunity to consider, the nature of the medications, the
				likely benefits and most common risks to the resident of receiving the
				medications, any other likely and most common consequences of receiving or not
				receiving the medications, and possible alternatives to the proposed
				medications.
9) "Licensed nurse" -
an advanced practice registered nurse, a registered nurse, or a
				licensed practical nurse
, as defined in the Nurse Practice Act.
				(Section 2-106.1(d) of the Act)
10)
"Psychotropic medication"
-
medication that is used
				for or listed as used for psychotropic, antidepressant, antimanic or
				antianxiety behavior modification or behavior management purposes in
				the
Prescribers Digital Reference database, the Lexicomp-online
				database, or the American Society of Health-System Pharmacists database.
				Psychotropic medication also includes any medication listed in
				42 CFR
				483.45(c)(3). (Section
				2-106.1(b-3) of the Act)
11)
"Surrogate decision maker" - an individual representing the resident's
				interests
in regard to consent to receive psychotropic medications,
as permitted by
Section 2-106.1(b-3) of the Act and this
				Section. (Section 2-106.1(b-3) of the Act)